title: CNS effects following the treatment of malignancy.
abstract: Corporeal and central nervous system (CNS) axis chemotherapy and radiotherapy have long been used for the effective treatment and prophylaxis of CNS, body malignancies, and leukaemias. However, they are not without their problems. Following the proliferation of magnetic resonance neuroimaging in recent years it has become clear that the spectrum of toxicity that these therapies produce ranges from subclinical white matter changes to overt brain necrosis. The effects are both direct and indirect and via different pathological mechanisms. Chronic and progressive changes can be detected many years after the initial intervention. In addition to leucoencephalopathic changes, grey matter changes are now well described. Changes may be difficult to distinguish from tumour recurrence, though may be reversible and remediable, and are thus very important to differentiate. In this review toxic effects are classified and their imaging appearances discussed, with reference to specific syndromes.
authors: Department of Neuroradiology, The West Wing, John Radcliffe Hospital, Oxford Radcliffe NHS Trust, Oxford, UK. rane@cantab.net
authors: N
authors: N
authors: Rane
authors: G
authors: G
authors: Quaghebeur
mesh_terms: D001927:Brain Diseases / Q000139:chemically induced*; D001930:Brain Injuries / Q000209:etiology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology*